Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Remimazolam for Intravenous Sedation in Outpatient Dental Procedures
jRCTs061220052Completed
- Sponsor
- Japan Society for the Promotion of Science
- Start
- Sep 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of remimazolam in Dental anxiety, sponsored by Japan Society for the Promotion of Science. Primary endpoint: Success rate of remimazolam alone in dental procedures under intravenous sedation. Started Sep 2022; status: completed.
02
Drugs
remimazolam
03
Conditions
Dental anxiety
Beyond the preview
Go deeper on jRCTs061220052.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCTs061220052.